Mellitus: A Scientific Statement From the American Heart Association and the Primary Prevention of Cardiovascular Diseases in People With Diabetes

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Atherosclerosis Risk in Communities (ARIC) Study

  2009cited by this paper
• Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC)

  2007cited by this paper
• Standards of medical care in diabetes--2006.

  2006cited by this paper
• Diet and Lifestyle Recommendations Revision 2006: A Scientific Statement From the American Heart Association Nutrition Committee

  2006cited by this paper
• A Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in Women

  2006cited by this paper
• Standards of Medical Care in Diabetes–2006

  2006cited by this paper
• Enhanced Risk Assessment in Asymptomatic Individuals With Exercise Testing and Framingham Risk Scores

  2005cited by this paper
• Predicting vascular risk in Type 1 diabetes: stratification in a hospital based population in Scotland

  2005cited by this paper
• The Effects of a Smoking Cessation Intervention on 14.5-Year Mortality

  2005cited by this paper
• The European Association for the Study of Diabetes.

  2005cited by this paper
• Diabetes and percutaneous coronary intervention in the setting of an acute coronary syndrome

  2005cited by this paper
• Antihypertensive therapy in diabetes mellitus: insights from ALLHAT and the Blood Pressure-Lowering Treatment Trialists’ Collaboration meta-analysis

  2005cited by this paper
• Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials.

  2005cited by this paper
• The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes.

  2005cited by this paper
• Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials

  2005cited by this paper
• Trends in cardiovascular complications of diabetes.

  2005cited by this paper
• Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.

  2005cited by this paper
• Nutrients and cardiovascular disease: no easy answers.

  2005cited by this paper
• Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.

  2005cited by this paper
• Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial.

  2005cited by this paper
• The Effects of Low-Carbohydrate versus Conventional Weight Loss Diets in Severely Obese Adults: One-Year Follow-up of a Randomized Trial

  2004cited by this paper
• Effects of omega-3 fatty acids on cardiovascular disease.

  2004cited by this paper
• Challenge of identifying patients with diabetes mellitus who are at low risk for coronary events by use of cardiac stress imaging.

  2004cited by this paper
• The need for a large-scale trial of fibrate therapy in diabetes: the rationale and design of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. [ISRCTN64783481]

  2004cited by this paper
• Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.

  2004cited by this paper
• AMERICAN DIABETES ASSOCIATION. DYSLIPIDEMIA MANAGEMENT IN ADULTS WITH DIABETES

  2004cited by this paper
• Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines

  2004cited by this paper
• Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes.

  2004cited by this paper
• Dyslipidemia management in adults with diabetes.

  2004cited by this paper
• Physical activity/exercise and type 2 diabetes.

  2004cited by this paper
• Meta-Analysis: Glycosylated Hemoglobin and Cardiovascular Disease in Diabetes Mellitus

  2004cited by this paper
• Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases

  2004cited by this paper
• Clinical Outcomes in the Diabetes Cohort of the International Verapamil SR-Trandolapril Study

  2004cited by this paper
• American College of Endocrinology Consensus Statement on Guidelines for Glycemic Control *

  2004cited by this paper
• Nutrition principles and recommendations in diabetes.

  2004cited by this paper
• The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

  2003cited by this paper
• Economic costs of diabetes in the US in 2002.

  2003cited by this paper
• Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes

  2003cited by this paper
• Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study.

  2003cited by this paper
• Seventh report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7): resetting the hypertension sails.

  2003cited by this paper
• A randomized trial of a low-carbohydrate diet for obesity.

  2003cited by this paper
• Lifetime risk for diabetes mellitus in the United States.

  2003cited by this paper
• Archimedes: a trial-validated model of diabetes.

  2003cited by this paper
• Heart rate recovery following maximal exercise testing as a predictor of cardiovascular disease and all-cause mortality in men with diabetes.

  2003cited by this paper
• Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial.

  2003cited by this paper
• Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes.

  2003cited by this paper
• MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial.

  2003cited by this paper
• The Evidence Base for Tight Blood Pressure Control in the Management of Type 2 Diabetes Mellitus

  2003cited by this paper
• Design of the cooperative study on glycemic control and complications in diabetes mellitus type 2: Veterans Affairs Diabetes Trial.

  2003cited by this paper
• Aspirin for the Primary Prevention of Cardiovascular Events: A Summary of the Evidence for the U.S. Preventive Services Task Force

  2002cited by this paper
• Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.

  2002cited by this paper
• Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

  2002cited by this paper
• Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

  2002cited by this paper
• Erratum: The UKPDS risk engine: A model for the risk of coronary heart disease in type II diabetes (UKPDS 56) (Clinical Science (2001) 101 (671-679))

  2002cited by this paper
• Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

  2002cited by this paper
• Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies

  2002cited by this paper
• Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy.

  2002cited by this paper
• The impact of diabetes mellitus and prior myocardial infarction on mortality from all causes and from coronary heart disease in men.

  2002cited by this paper
• Diabetes and all-cause and coronary heart disease mortality among US male physicians.

  2001cited by this paper
• The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up.

  2001cited by this paper
• Study Rationale and Design of ADVANCE: Action in Diabetes and Vascular disease – preterax and diamicron MR controlled evaluation

  2001cited by this paper
• Effects of Diet and Sodium Intake on Blood Pressure: Subgroup Analysis of the DASH-Sodium Trial

  2001cited by this paper
• Fish oil supplementation in type 2 diabetes: a quantitative systematic review.

  2000cited by this paper
• Diabetes and coronary heart disease.

  2000cited by this paper
• Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes.

  2000cited by this paper
• Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.

  2000cited by this paper
• MORTALITY FROM CORONARY HEART DISEASE IN SUBJECTS WITH TYPE 2 DIABETES AND IN NONDIABETIC SUBJECTS WITH AND WITHOUT PRIOR MYOCARDIAL INFARCTION

  2000cited by this paper
• United Kingdom Prospective Diabetes Study(UKPDS)からのメッセージとその解釈

  1999cited by this paper
• Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.

  1998cited by this paper
• Prediction of coronary heart disease using risk factor categories.

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

  1998cited by this paper
• Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial.

  1995cited by this paper
• The Antioxidant Vitamins and Cardiovascular Disease: A Critical Review of Epidemiologic and Clinical Trial Data

  1995cited by this paper
• Coronary Heart Disease Incidence in NIDDM Patients In The Helsinki Heart Study

  1992cited by this paper
• Aspirin effects on mortality and morbidity in patients with diabetes mellitus. Early Treatment Diabetic Retinopathy Study report 14. ETDRS Investigators.

  1992cited by this paper
• Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.

  1987cited by this paper

• Association Between Body Mass Index and Glycemic Control in Type 2 Diabetes Mellitus: A Cross-Sectional Study

  2025cites this paper
• Impact of a diabetes diagnosis on preventive care utilization among middle-life adults in the United States: A mediation analysis of depressive symptoms

  2025cites this paper
• Frameshift variation in the HMG-CoA reductase gene and unresponsiveness to cholesterol-lowering drugs in type 2 diabetes mellitus patients

  2025cites this paper
• Early effective intervention can significantly reduce all-cause mortality in prediabetic patients: a systematic review and meta-analysis based on high-quality clinical studies

  2024cites this paper
• Comparative Analysis of Biomarkers in Type 2 Diabetes Patients With and Without Comorbidities: Insights Into the Role of Hypertension and Cardiovascular Disease

  2024cites this paper
• Diabetes Mellitus and Coronary Revascularization: Comparing Outcomes Between Coronary Artery Bypass Grafting and Percutaneous Coronary Intervention

  2024cites this paper
• Associations between dose–response of serum creatinine and type 2 diabetes mellitus risk: consistent and robust evidence from a systematic review and meta-analysis

  2024cites this paper
• A Descriptive Review of the Action Mechanisms of Berberine, Quercetin and Silymarin on Insulin Resistance/Hyperinsulinemia and Cardiovascular Prevention

  2023cites this paper
• Effects of synbiotics supplementation on anthropometric and lipid profile parameters: Finding from an umbrella meta-analysis

  2023cites this paper
• Effect of hemoglobin A1c management levels on coronary physiology evaluated by quantitative flow ratio in patients who underwent percutaneous coronary intervention

  2023cites this paper
• Long-term quality-of-care score for predicting the occurrence of acute myocardial infarction in patients with type 2 diabetes mellitus

  2023cites this paper
• Assessment of subclinical left ventricular systolic dysfunction in patients with type 2 diabetes: Relationship with HbA1c and microvascular complications

  2023cites this paper
• Optimal medical therapy improves outcomes in patients with diabetes mellitus and acute myocardial infarction.

  2023cites this paper
• The Relationship between the Angiographic Atherosclerotic Burden and the Inflammatory Factors in Diabetic and Non-Diabetic Patients with Coronary Artery Disease

  2023cites this paper
• Contemporary Use of Cardiovascular Risk Reduction Strategies in Type 2 Diabetes. Insights from The Diabetes Collaborative Registry.

  2023cites this paper
• The Diabetes-Heart Disease Connection: Recent Discoveries and Implications.

  2023cites this paper
• High‐fat diet and oral infection induced type 2 diabetes and obesity development under different genetic backgrounds

  2023cites this paper
• Role of Internet of things in diabetes healthcare: Network infrastructure, taxonomy, challenges, and security model

  2023cites this paper
• Diagnostic and therapeutic characteristics of diabetes mellitus and risk of out-of-hospital cardiac arrest

  2022cites this paper
• Impact of micro‐ and macrovascular complications of type 2 diabetes on quality of life: Insights from the DISCOVER prospective cohort study

  2022cites this paper
• Comparative study of pure tone audiometry in diabetics and non-diabetics

  2022influential citation
• Vascular Calcification in Diabetic Kidney Disease

  2022cites this paper
• Cardiovascular risk and protective factors in adults with and without diabetes mellitus (Italy, 2016–19)

  2022cites this paper
• A Cross-sectional Study on the Development of Diabetic Cardiovascular Complications in Type 2 Diabetes Mellitus in a South Indian Tertiary Care Hospital

  2022cites this paper
• Studying the Pharmagenomic effect of Portulaca oleracea extract on anti-diabetic therapy using the Collaborative Cross mice

  2022cites this paper
• Short-term effects of modest salt reduction combined with DASH diet on changing salt eating habits in hypertensive patients with type II diabetes

  2022cites this paper
• Prevalence and predictors of stroke among individuals with prediabetes and diabetes in Florida

  2022cites this paper
• Prevalence of long-term complications in inpatients with diabetes mellitus in China: a nationwide tertiary hospital-based study

  2022cites this paper
• Molecular Biological and Clinical Understanding of the Statin Residual Cardiovascular Disease Risk and Peroxisome Proliferator-Activated Receptor Alpha Agonists and Ezetimibe for Its Treatment

  2022cites this paper
• 10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2022.

  2021cites this paper
• Change in Proteinuria and Renal Function in Patients with Type 2 Diabetes Receiving Standard Treatment

  2021cites this paper
• Running to save sight: The effects of exercise on retinal health and function

  2021cites this paper
• Glucagon-like Peptide-1 Receptor Agonists and Cardioprotective Benefit in Patients with Type 2 Diabetes Without Baseline Metformin: A Systematic Review and Update Meta-analysis

  2021cites this paper
• Association between Coronary Artery Calcium Score and Clinical Events at 1 Year among Asymptomatic Patients

  2021cites this paper
• Risk Factors of Peripheral Vascular Disease in Diabetes Mellitus in Abbottabad, Pakistan: A Cross-Sectional Study

  2021cites this paper
• Incidence Rates and Predictors of Microvascular and Macrovascular Complications in Patients with Type 2 Diabetes: Results from the Longitudinal Global DISCOVER Study.

  2021cites this paper
• SIRM–SIC appropriateness criteria for the use of Cardiac Computed Tomography. Part 1: Congenital heart diseases, primary prevention, risk assessment before surgery, suspected CAD in symptomatic patients, plaque and epicardial adipose tissue characterization, and functional assessment of stenosis

  2021cites this paper
• Long-term outcomes after renal denervation in an Asian population: results from the Global SYMPLICITY Registry in South Korea (GSR Korea)

  2021cites this paper
• Modulation of insulin resistance by renin angiotensin system inhibitors: implications for cardiovascular prevention.

  2021cites this paper
• Current concepts and clinical importance of glycemic variability.

  2021cites this paper
• Why Are Individuals With Diabetes Less Active? The Mediating Role of Physical, Emotional, and Cognitive Factors.

  2021cites this paper
• Prevalence of the Use of Aspirin and Statins for Preventing Cardiovascular Events in the Colombian Population with Type 2 Diabetes Mellitus: Comparison of 2008 and 2018

  2021cites this paper
• The Effect of Implementation Intention on Improving Physical Activity Level and Cardiovascular Fitness in Patients with Type 2 Diabetes: A Randomized Control Study

  2021cites this paper
• On the effects of obesity treatment

  2021cites this paper
• Stroke prevention in patients with type 2 diabetes mellitus or prediabetes: recommendations of the Spanish Society of Neurology’s Stroke Study Group

  2021cites this paper
• Metal-based nanoparticles: Promising tools for the Management of Cardiovascular Diseases.

  2021cites this paper
• Pitavastatin and metformin synergistically activate apoptosis and autophagy in pancreatic cancer cells

  2021cites this paper
• Trial of a New Diabetes Education Model: Closing the Gap in Health Disparity for People with Diabetes

  2021cites this paper
• Cardiac Autonomic Neuropathy in Diabetes Mellitus Patients – Are We Aware of the Consequences?

  2020cites this paper
• Clinical utility of serum cystatin C for prediction of multi-vessel disease by coronary angiography in type 2 diabetes mellitus patients with normal renal function

  2020cites this paper
• Stroke prevention in patients with type 2 diabetes or prediabetes. Recommendations from the Cerebrovascular Diseases Study Group, Spanish Society of Neurology.

  2020cites this paper
• The efficacy and safety of cold atmospheric plasma as a novel therapy for diabetic wound in vitro and in vivo

  2020cites this paper
• Correlation between gene polymorphism in angiotensin II type 1 receptor and type 2 diabetes mellitus complicated by hypertension in a population of Inner Mongolia

  2020cites this paper
• Association between high-density lipoprotein cholesterol and type 2 diabetes mellitus among Chinese: the Beijing longitudinal study of aging

  2020cites this paper
• Medical and Dental Electronic Health Record Reporting Discrepancies in Integrated Patient Care

  2020cites this paper
• Individual and joint effects of metformin and statins on mortality among patients with high‐risk prostate cancer

  2020cites this paper
• Risk analysis for cardiovascular complication based on the atherogenic index of plasma of type 2 diabetes mellitus patients in Medan, Indonesia

  2020cites this paper
• Extent and Associated Factors of Obesity among Patients at a Specialized Outpatient Clinic in Uganda

  2020cites this paper
• Outcomes Associated With Oral Anticoagulants Plus Antiplatelets in Patients With Newly Diagnosed Atrial Fibrillation

  2020cites this paper
• Role of Advanced Glycated End Products (AGEs) in Predicting Diabetic Complications Using Machine Learning Tools: A Review from Biological Perspective

  2020cites this paper
• Food Habits, Weight Status and Metabolic Risk Factors in a Group of Adults in Tehran

  2020cites this paper
• Trajectories of Adherence to Low-Dose Aspirin Treatment Among the French Population

  2020cites this paper
• The Association of 3-Hydroxy-3-Methylglutaryl-CoA Reductase, Apolipoprotein E, and Solute Carrier Organic Anion Genetic Variants with Atorvastatin Response among Jordanian Patients with Type 2 Diabetes

  2020cites this paper
• Assessment of Cardiovascular Risk Factors in Patients with Type 2 Diabetes in Upper Egypt Villages and Obesity: Targets and Therapy

  2020cites this paper
• Reduced Stiffness and Augmented Traction Force in Type 2 Diabetic Coronary Microvascular Smooth Muscle.

  2020cites this paper
• Effects of synbiotic consumption on lipid profile: a systematic review and meta-analysis of randomized controlled clinical trials

  2020cites this paper
• Evaluation of Aerobic Exercise Intensity in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus

  2020cites this paper
• Influence of health education on clinical parameters in type 2 diabetic subjects with and without hypertension: a longitudinal, comparative analysis in routine primary care settings.

  2020cites this paper
• Prognosis and Outcome: State of the Evidence

  2019cites this paper
• Incremental risk of cardiovascular disease and/or chronic kidney disease for future ASCVD and mortality in patients with type 2 diabetes mellitus: ACCORD trial.

  2019cites this paper
• Frequency of aspirin use in patients with type 2 diabetes: Is there any effect of concomitant diseases?

  2019cites this paper
• Discovering Data-Driven Actionable Intelligence for Clinical Decision Support

  2019cites this paper
• A 2-es típusú cukorbetegség kardiovaszkuláris megbetegedésre és összmortalitásra kifejtett korfüggő hatása: országos elemzés a NEAK adatbázisa alapján

  2019cites this paper
• Optimal Duration for Clopidogrel Suspension Prior to Coronary Artery Bypass Grafting

  2019cites this paper
• Evidence discussing glycaemic targets that need to be achieved to reduce macrovascular disease risk in type 2 diabetes

  2019cites this paper
• Pharmacokinetics of fixed-dose combination of atorvastatin and metformin compared with individual tablets

  2019cites this paper
• 10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2020

  2019cites this paper
• Correlation between Diabetic Retinopathy and the Severity of Coronary Artery Disease Determined by Coronary Angiography in Patients with Type II Diabetes Mellitus

  2019cites this paper
• Hypertension and Diabetes

  2019cites this paper
• Disparities in mortality among adults with and without diabetes by sex and race.

  2019cites this paper
• Therapeutic Options Targeting Oxidative Stress, Mitochondrial Dysfunction and Inflammation to Hinder the Progression of Vascular Complications of Diabetes

  2019cites this paper
• The Association of Physical Activity With Carotid Intima Media Thickening in a Healthy Older Population: Cooper Center Longitudinal Study.

  2019cites this paper
• SCREENING FOR COMPLICATIONS OF DIABETES MELLITUS

  2019cites this paper
• Evaluation of Glycated Hemoglobin (HbA1c) in Acute Coronary Syndrome (ACS)

  2019cites this paper
• Coronary Artery Disease Impact of Pharmacist Interventions on the Long-Term Clinical Outcomes in Patients with Myocardial Infarction

  2019cites this paper
• The Effect of Nutrition Education Program on Overweight/Obese Patients with Non-Alcoholic Fatty Liver Disease: a Single-Blind Parallel Randomized Controlled Trial

  2019cites this paper
• Glycemic control and lipid outcomes in children and adolescents with type 2 diabetes

  2019cites this paper
• Association between difference in blood pressure reduction and risk of cardiovascular events in a type 2 diabetes population: A meta-regression analysis.

  2019cites this paper
• Non-High-Density Lipoprotein Cholesterol and Guidelines for Cholesterol Lowering in Recent History.

  2019cites this paper
• Standards of Medical Care in Diabetes—2020 Abridged for Primary Care Providers

  2019cites this paper
• Relationships between blood pressure lowering therapy and cardiovascular events in hypertensive patients with coronary artery disease and type 2 diabetes mellitus: The HIJ-CREATE sub-study.

  2019cites this paper
• DDDT_A_193254 1623..1632

  2019cites this paper
• Inexpensive and flexible nanographene-based electrodes for ubiquitous electrocardiogram monitoring

  2019cites this paper
• Regulation of intestinal lipid and lipoprotein metabolism by the proglucagon-derived peptides glucagon like peptide 1 and glucagon like peptide 2

  2018influential citation
• Low serum creatinine predicts risk for type 2 diabetes

  2018cites this paper
• Alleviation of Cardiac Damage by Dietary Fenugreek (Trigonella foenum-graecum) Seeds is Potentiated by Onion (Allium cepa) in Experimental Diabetic Rats via Blocking Renin–Angiotensin System

  2018cites this paper
• Epidemiologic Characterization of Risk for Cardiovascular Diseases

  2018cites this paper
• Cardiovascular risk in type 2 diabetes patients

  2018cites this paper
• A smart wearable system for short-term cardiovascular risk assessment with emotional dynamics

  2018cites this paper
• 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

  2018cites this paper